| 000 | 01245 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511160233.0 | ||
| 264 | 0 | _c19760925 | |
| 008 | 197609s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00229a022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChakrabarti, J K | |
| 245 | 0 | 0 |
_aAdamantane and protoadamantanealkanamines as potential anti-Parkinson agents. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJul 1976 |
||
| 300 |
_a967-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdamantane _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAmines _xchemical synthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBody Temperature _xdrug effects |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xchemical synthesis |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReserpine _xantagonists & inhibitors |
| 700 | 1 | _aHotten, T M | |
| 700 | 1 | _aSutton, S | |
| 700 | 1 | _aTupper, D E | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 19 _gno. 7 _gp. 967-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00229a022 _zAvailable from publisher's website |
| 999 |
_c947649 _d947649 |
||